XNAS
MAZE
Market cap2.01bUSD
Dec 05, Last price
41.71USD
1D
-2.09%
1Q
162.66%
IPO
178.07%
Name
Maze Therapeutics Inc
Chart & Performance
P/E
—
P/S
—
EPS
1.09
Div Yield, %
—
Shrs. gr., 5y
—
Rev. gr., 5y
%
Revenues
168m
Net income
52m
CFO
76m
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Valuation
Title in thousands, except ratios and share amounts | FY |
|---|---|
| 2024‑12 | |
| Income | |
Revenues | |
Cost of revenue | |
Unusual Expense (Income) | |
NOPBT | |
NOPBT Margin | |
Operating Taxes | |
Tax Rate | |
NOPAT | |
Net income | |
Dividends | |
Dividend yield | |
Proceeds from repurchase of equity | |
BB yield | |
| Debt | |
Debt current | |
Long-term debt | |
Deferred revenue | |
Other long-term liabilities | |
Net debt | |
| Cash flow | |
Cash from operating activities | |
CAPEX | |
Cash from investing activities | |
Cash from financing activities | |
FCF | |
| Balance | |
Cash | |
Long term investments | |
Excess cash | |
Stockholders' equity | |
Invested Capital | |
ROIC | |
ROCE | |
| EV | |
Common stock shares outstanding | |
Price | |
Market cap | |
EV | |
EBITDA | |
EV/EBITDA | |
Interest | |
Interest/NOPBT |